Merus N.V. Common Shares (MRUS)

Merus N.V. (MRUS) stock surges to a 52-week high following Genmab acquisition news and positive clinical trial data. Increased social media buzz reflects strong market confidence.

About Merus N.V. Common Shares

Merus N.V. is a biotechnology company focused on developing antibody-based therapeutics for cancer.
Merus N.V. Common Shares uses the ticker $MRUS for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

• Merus N.V. Common Shares (MRUS) social dominance is up 141.67% from the previous week.
• Merus N.V. Common Shares (MRUS) Galaxy Score™ is up 32.14% from the previous month.
• Merus N.V. Common Shares (MRUS) sentiment is up 34% from the previous week.
• Merus N.V. Common Shares (MRUS) engagements is up 131.82% from the previous week.

Price: $90

Price 24-Hour Time-Series Raw Data
The stock price has surged to a 52-week high, driven by acquisition news from Genmab at a significant premium and positive clinical trial results, with increased social media activity reflecting strong market confidence.

24-Hour: -7.08%

1-Year High: $97 on 2025-12-19
1-Year Low: $34.90 on 2025-04-08

AltRank: [-----]

AltRank 24-Hour Time-Series Raw Data
Merus N.V. Common Shares (MRUS) is currently AltRank #1,727 based on combined combined social and market metrics Daily Average: [---]
[--] Week: [-----] [----]
[--] Month: [-----] +1,016
[--] Months: [-----] +1,258
[--] Year: [-----] +770
1-Year High: [-----] on 2026-01-28
1-Year Low: [--] on 2025-05-24

Galaxy Score: [-----]

Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] +5
[--] Month: [--] +9
[--] Months: [--] [---]
[--] Year: [--] +6
1-Year High: [--] on 2025-07-10
1-Year Low: [--] on 2025-12-11

Engagements: [---] (24h)

Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [------]
[--] Week: [-----] +132%
[--] Month: [------] -92%
[--] Months: [---------] -7.90%
[--] Year: [---------] -33%
1-Year High: [-------] on 2025-09-29
1-Year Low: [--] on 2026-02-08

Engagements by network (24h): X: [---] Reddit: [--]

Mentions: [--] (24h)

Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [--] -11%
[--] Month: [---] -23%
[--] Months: [-----] -49%
[--] Year: [-----] +285%
1-Year High: [-----] on 2025-07-10
1-Year Low: [--] on 2025-12-07

Mentions by network (24h): X: [--] Reddit: [--]

Creators: [--] (24h)

Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Merus N.V. Common Shares (MRUS) in the last [--] hours which is up 56% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [--] -3.20%
[--] Month: [--] -34%
[--] Months: [-----] -53%
[--] Year: [-----] +497%
1-Year High: [---] on 2025-09-29
1-Year Low: [--] on 2025-12-07

Sentiment: 100%

Sentiment 24-Hour Time-Series Raw Data
Current Value: 100%
Daily Average: 77%
[--] Week: 67% +17%
[--] Month: 83% -3%
[--] Months: 83% -11%
[--] Year: 83% +33%
1-Year High: 100% on 2025-04-13
1-Year Low: 27% on 2025-03-02

Most Supportive Themes:

• Positive Clinical Trial Results: (40%) Merus N.V. Common Shares (MRUS) has shown positive clinical trial results, contributing to market confidence.
• Acquisition News: (35%) The company is experiencing increased social media activity due to acquisition news from Genmab at a significant premium.

Most Critical Themes:

Social Dominance: 0.0016%

Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.0016%
Daily Average: 0.013%
[--] Week: 0.0029% +0.0017%
[--] Month: 0.007% +0.0021%
[--] Months: 0.007% -0.0071%
[--] Year: 0.007% +0.0011%
1-Year High: 0.153% on 2025-07-10
1-Year Low: 0.0008% on 2025-12-07

Market Dominance: 0.00764%

Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00764%
Daily Average: 0%
1-Year High: 0.013% on 2025-03-31
1-Year Low: 0.00382% on 2025-05-15

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing